13 pending office actions • 3 clients
| Client (Assignee) | Pending OAs |
|---|---|
| Gilead Sciences, Inc. | 9 |
| The Trustees of the University of Pennsylvania | 2 |
| Tmunity Therapeutics Inc. | 2 |
| App # | Title | Client | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|---|
| 18655876 | METHODS OF PREPARING 1'-CYANO NUCLEOSIDES | Gilead Sciences, Inc. | BERRY, LAYLA D | 1693 | Non-Final OA | May 06, 2024 |
| 18512088 | METHODS FOR TREATING POXVIRUS INFECTIONS | Gilead Sciences, Inc. | CHAO, ALLEN | 1622 | Non-Final OA | Nov 17, 2023 |
| 18381258 | CAR-T CONSTRUCTS COMPRISING A NOVEL CD19 BINDER COMBINED WITH IL18 AND METHODS OF USING THE SAME | The Trustees of the University of Pennsylvania | GAMETT, DANIEL C | 1647 | Non-Final OA | Oct 18, 2023 |
| 18381215 | CD19 BINDERS, CAR-T CONSTRUCTS COMPRISING THE SAME, AND METHODS OF USING THE SAME | The Trustees of the University of Pennsylvania | EDGINGTONGIORDANO, FRANCESCA | 1643 | Non-Final OA | Oct 18, 2023 |
| 18243812 | METHODS FOR TREATMENT OF VIRAL INFECTIONS | Gilead Sciences, Inc. | LEWIS, PATRICK T | 1691 | Non-Final OA | Sep 08, 2023 |
| 18365919 | SARS-COV2 MAIN PROTEASE INHIBITORS | Gilead Sciences, Inc. | BORALSKY, LUKE ALAN | 1624 | Non-Final OA | Aug 04, 2023 |
| 18345547 | THERAPEUTIC COMPOUNDS USEFUL FOR THE PROPHYLACTIC OR THERAPEUTIC TREATMENT OF AN HIV VIRUS INFECTION | Gilead Sciences, Inc. | DEKARSKE, MADELINE MCGUIRE | 1622 | Non-Final OA | Jun 30, 2023 |
| 18215217 | SOLID FORMS OF A NUCLEOSIDE ANALOGUE AND USES THEREOF | Gilead Sciences, Inc. | SEITZ, ANTHONY JOSEPH | 1629 | Non-Final OA | Jun 28, 2023 |
| 18314989 | SOLID FORMS OF A COMPOUND FOR MODULATING COT | Gilead Sciences, Inc. | LEE, ANDREW P | 1691 | Non-Final OA | May 10, 2023 |
| 18115895 | COMPOUNDS AND METHODS FOR TREATMENT OF VIRAL INFECTIONS | Gilead Sciences, Inc. | NOTTINGHAM, KYLE GREGORY | 1621 | Non-Final OA | Mar 01, 2023 |
| 18022968 | VECTOR-FREE PROCESS FOR MANUFACTURE OF ENGINEERED IMMUNE CELLS | Tmunity Therapeutics Inc. | SU-TOBON, QIWEN NMN | 1636 | Non-Final OA | Feb 23, 2023 |
| 17940186 | ALTERNATIVE GENERATION OF ALLOGENEIC HUMAN T CELLS | Tmunity Therapeutics Inc. | WESTON, ALYSSA G | 1633 | Final Rejection | Sep 08, 2022 |
| 17612426 | DOSAGE REGIMENS FOR VACCINES | Gilead Sciences, Inc. | JADHAO, SAMADHAN JAISING | 1672 | Non-Final OA | Nov 18, 2021 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial